-+ 0.00%
-+ 0.00%
-+ 0.00%

Atossa Therapeutics FY 2024 GAAP EPS $(0.20) Beats $(0.22) Estimate, Cash $71.1M

Benzinga·03/25/2025 12:05:40
Listen to the news
Atossa Therapeutics (NASDAQ:ATOS) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.22) by 9.09 percent. This is a 16.67 percent increase over losses of $(0.24) per share from the same period last year.